ENDRA Life Sciences Amends Merger Terms, Sets Cash Floor
ENDRA Life Sciences has amended its merger agreement with Renergen, resetting the minimum cash requirement to approximately $3.8 million and removing the classified board provision.
ENDRA Life Sciences has amended its merger agreement with Renergen, resetting the minimum cash requirement to approximately $3.8 million and removing the classified board provision.